title: [An elderly case whose residual malignant lymphoma was completely remitted by oral etoposide treatment using unusual dosing schedule].
abstract: In a 72-year-old man with malignant lymphoma (Hodgkin's disease, nodular sclerosis type, Stage III S), complete remission was induced by intravenous drip of adriamycin and oral administration of etoposide. After that, a maintenance dose of etoposide (25 mg) was administered every 3 days without observable side effects. From these results, we considered that the dose level and interval of administration are both important for chemotherapy in elderly patients.
authors.affiliation: Dept. of Internal Medicine, Yamamoto Daisan Hospital.
authors.forename: T
authors.initials: T
authors.lastname: Soga
authors.forename: Y
authors.initials: Y
authors.lastname: Sakane
authors.forename: S
authors.initials: S
authors.lastname: Fukuhara
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D012074:Remission Induction
chemical_list: D005047:Etoposide; D004317:Doxorubicin